Tracking 6,900 survivors to build better cancer checkups
NCT ID NCT02229916
Summary
This study aims to improve the long-term monitoring of men who have been treated for testicular cancer. It will follow 6,900 survivors in Switzerland, Austria, and Germany to see which follow-up tests are most effective at catching a cancer return and to document long-term side effects of treatment. The goal is to create better, more personalized check-up schedules that protect patients' health without unnecessary procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TESTICULAR NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kantonsspital St.Gallen; Onkologie/Haematologie
RECRUITINGSankt Gallen, 9007, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.